Identification of Natural Compounds as Inhibitors of Pyruvate Kinase M2 for Cancer Treatment
The reliance of tumor cells on aerobic glycolysis is one of the emerging hallmarks of cancer. Pyruvate kinase M2 (PKM2), an important enzyme of glycolytic pathway, is highly expressed in a number of cancer cells. Tumor cells heavily depend on PKM2 to fulfill their divergent energetic and biosyntheti...
Main Authors: | Iqra Sarfraz, Azhar Rasul, Farhat Jabeen, Tayyaba Sultana, Şevki Adem |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/20/7113 |
Similar Items
-
Aerobic Glycolysis in the Retina: Functional Roles of Pyruvate Kinase Isoforms
by: Raju V. S. Rajala, et al.
Published: (2020-04-01) -
Pyruvate Kinase and Gastric Cancer: A Potential Marker
by: Filipa Macedo, et al.
Published: (2018-06-01) -
Protein kinase function of pyruvate kinase M2 and cancer
by: Xun Chen, et al.
Published: (2020-10-01) -
Pyruvate Kinase, Inflammation and Periodontal Disease
by: Melissa M. Grant
Published: (2021-06-01) -
Cryptosporidium parvum Pyruvate Kinase Inhibitors With in vivo Anti-cryptosporidial Efficacy
by: Shahbaz M. Khan, et al.
Published: (2022-01-01)